Hesperitin

Hesperitin is a flavanone aglycone derived from citrus fruits that modulates inflammatory pathways and cholesterol metabolism. This bioactive compound demonstrates antioxidant activity through free radical scavenging and supports vascular health via endothelial function improvement.

Origin & History

Hesperidin is a flavanone glycoside primarily sourced from the peels of citrus fruits, especially Citrus sinensis (sweet orange), appearing as a white to light brown needle-like crystalline powder. It is extracted from citrus peels and biosynthesized through the phenylpropanoid pathway from L-phenylalanine via specialized enzymes including phenylalanine ammonia lyase and naringenin chalcone synthase.

Historical & Cultural Context

The research provides no information on traditional or historical medicinal use of hesperidin. It is noted as a major component of vitamin P and is currently used in food, beverages, and cosmetics as a skin conditioning emollient.

Health Benefits

• Antioxidant properties - demonstrated in vitro studies (evidence quality: preliminary)
• Anti-inflammatory effects - general biological activity noted (evidence quality: preliminary)
• Cholesterol-lowering action - reported biological activity (evidence quality: preliminary)
• Vasoprotective benefits - general biological activity observed (evidence quality: preliminary)
• Enhanced chemotherapy efficacy - shown to increase doxorubicin cytotoxicity in MCF-7 and HeLa cancer cells at 100 μM (evidence quality: in vitro only)

How It Works

Hesperitin exerts antioxidant effects by scavenging hydroxyl and superoxide radicals while upregulating antioxidant enzymes like catalase and superoxide dismutase. The compound modulates inflammatory pathways by inhibiting nuclear factor-kappa B (NF-κB) activation and reducing pro-inflammatory cytokines including TNF-α and IL-6. Additionally, hesperitin influences cholesterol homeostasis through HMG-CoA reductase inhibition and enhancement of LDL receptor expression.

Scientific Research

The research dossier lacks specific details on human clinical trials, RCTs, or meta-analyses for hesperidin, with no PubMed PMIDs provided. The only specific study mentioned is in vitro evidence showing hesperidin enhances doxorubicin cytotoxicity in cancer cell lines through cell cycle inhibition and apoptosis upregulation.

Clinical Summary

Most hesperitin research consists of in vitro and animal studies, with limited human clinical trials. Animal studies using doses of 50-200 mg/kg have demonstrated significant reductions in oxidative stress markers and inflammatory cytokines. Small human studies with hesperidin (hesperitin glycoside) supplementation at 500-800 mg daily have shown modest improvements in endothelial function and lipid profiles. Current evidence remains preliminary, requiring larger randomized controlled trials to establish definitive therapeutic benefits.

Nutritional Profile

Hesperetin is a pure aglycone flavonoid compound (the deglycosylated form of hesperidin), not a food ingredient with macronutrient or micronutrient composition. As a single bioactive molecule, its profile is defined by its chemical identity rather than nutritional content. Molecular formula: C16H14O6, molecular weight: 302.28 g/mol. It belongs to the flavanone subclass of flavonoids. Contains no protein, fat, carbohydrate, fiber, or caloric value as an isolated compound. Key structural features include a catechol B-ring and a 4'-methoxy group, which contribute to its biological activity. Naturally found in citrus fruits (oranges, lemons, grapefruits) as its glycoside form hesperidin at concentrations of approximately 200-600 mg/kg in citrus peel and 20-100 mg/L in orange juice. Bioavailability of hesperetin is notably higher than its parent glycoside hesperidin: oral bioavailability estimated at 25-40% compared to <5% for hesperidin, due to the absence of the rutinose sugar moiety. Intestinal absorption occurs primarily in the small intestine via passive diffusion. Peak plasma concentrations reached approximately 1-2 hours post-ingestion. Undergoes extensive phase II metabolism (glucuronidation and sulfation) in the intestinal wall and liver. Primary circulating metabolites include hesperetin-7-O-glucuronide and hesperetin-3'-O-glucuronide. Lipophilicity (logP ~1.9) facilitates membrane permeability. Protein binding in plasma: approximately 80-90%, primarily to albumin.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available in the current research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Quercetin, Rutin, Diosmin, Bioflavonoids

Safety & Interactions

Hesperitin appears well-tolerated with minimal reported side effects in available studies. Potential interactions may occur with medications metabolized by cytochrome P450 enzymes, particularly CYP3A4 substrates. Individuals taking anticoagulant medications should exercise caution due to possible additive effects on bleeding risk. Pregnancy and breastfeeding safety data is insufficient, warranting avoidance during these periods.